Share Twitter LinkedIn Facebook Email Rita Sanghvi Mehta, MD, UC Irvine Health, explains High-Dose Fulvestrant Vs. Loading Dose | Loading Dose Prevents Early Progressions at MOASC 2018.
ASCO 2025 Guidelines on Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer: A Game-Changer in Oncology ASCO 5 Mins Read
2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC Breast 6 Mins Read